MICHALCOVÁ, Jana, Karel VAŠUT, M. AIRAKSINEN and K. BIELAKOVA. Inclusion of medication-related fall risk in fall risk assessment tool in geriatric care units. BMC GERIATRICS. LONDON: BMC, 2020, vol. 20, No 1, p. 1-11. ISSN 1471-2318. Available from: https://dx.doi.org/10.1186/s12877-020-01845-9.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Inclusion of medication-related fall risk in fall risk assessment tool in geriatric care units
Authors MICHALCOVÁ, Jana (203 Czech Republic, guarantor, belonging to the institution), Karel VAŠUT (203 Czech Republic, belonging to the institution), M. AIRAKSINEN and K. BIELAKOVA.
Edition BMC GERIATRICS, LONDON, BMC, 2020, 1471-2318.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.921
RIV identification code RIV/00216224:14160/20:00118182
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.1186/s12877-020-01845-9
UT WoS 000587115700001
Keywords in English Older adults; Fall risk; Medication; Hospital; Nursing home; Preventive risk management
Tags rivok, ÚAF
Tags International impact, Reviewed
Changed by Changed by: PharmDr. Jitka Michlíčková, učo 151288. Changed: 16/2/2021 14:26.
Abstract
Background Falls are common undesirable events for older adults in institutions. Even though the patient's fall risk may be scored on admission, the medication-induced fall risk may be ignored. This study developed a preliminary categorization of fall-risk-increasing drugs (FRIDs) to be added as a risk factor to the existing fall risk assessment tool routinely used in geriatric care units. Methods Medication use data of older adults who had experienced at least one fall during a hospital ward or a nursing home stay within a 2-year study period were retrospectively collected from patient records. Medicines used were classified into three risk categories (high, moderate and none) according to the fall risk information in statutory summaries of product characteristics (SmPCs). The fall risk categorization incorporated the relative frequency of such adverse drug effects (ADEs) in SmPCs that were known to be connected to fall risk (sedation, orthostatic hypotension, syncope, dizziness, drowsiness, changes in blood pressure or impaired balance). Also, distribution of fall risk scores assessed on admission without considering medications was counted. Results The fall-experienced patients (n = 188, 128 from the hospital and 60 from nursing home records) used altogether 1748 medicaments, including 216 different active substances. Of the active substances, 102 (47%) were categorized as high risk (category A) for increasing fall risk. Fall-experienced patients (n = 188) received a mean of 3.8 category A medicines (n = 710), 53% (n = 375) of which affected the nervous and 40% (n = 281) the cardiovascular system. Without considering medication-related fall risk, 53% (n = 100) of the patients were scored having a high fall risk (3 or 4 risk scores). Conclusion It was possible to develop a preliminary categorization of FRIDs basing on their adverse drug effect profile in SmPCs and frequency of use in older patients who had experienced at least one documented fall in a geriatric care unit. Even though more than half of the fall-experienced study participants had high fall risk scores on admission, their fall risk might have been underestimated as use of high fall risk medicines was common, even concomitant use. Further studies are needed to develop the FRID categorization and assess its impact on fall risk.
PrintDisplayed: 9/10/2024 16:45